Biblio
2022
Klement P, Fiedler W, Gabdoulline R, Dallmann L-K, Wienecke CPhiline, Schiller J, Kandziora C, Teich K, Heida B, Büttner K, et al. Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy. Ann Hematol. 2022.
2019
Chaturvedi A, Goparaju R, Gupta C, Weder J, Klünemann T, Cruz MMaria Arau, Kloos A, Goerlich K, Schottmann R, Othman B, et al. In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding site. Leukemia. 2019.